| GTO ID | GTC0604 |
| Trial ID | ChiCTR1900023957 |
| Disease | Acute Lymphoblastic Leukemia |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Co-treatment | HSCT |
| Recruitment status | Recruiting |
| Title | CAR-T therapy followed by haploidentical HSCT have prominent therapeutic efficacy for patients with relapsed/refractory acute lymphoblastic leukemia |
| Year | 2019 |
| Country | China |
| Company sponsor | the First Affiliated Hospital, School of Medicine, Zhejiang University |
| Cohort1: HSCT | |||||||||||||||||||
|
|||||||||||||||||||
| Cohort2: no HSCT | |||||||||||||||||||
|
|||||||||||||||||||